4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001780664-26-000002
President and COO sold 92,823 shares at an average $16.09 ($1,493,428)
- President and COO acquired 79,809 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
RUBINSTEIN JULIE · President and COO
Table I: Non-derivative
10 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-03 | Exercise or conversion : show line 1 in the form 10b5-1 | +14,722 | $6.55 | $96,429 | 602,971 | D |
| 2026-03-03 | Exercise or conversion : show line 2 in the form 10b5-1 | +11,881 | $12.14 | $144,235 | 614,852 | D |
| 2026-03-03 | Sale : show line 3 in the form 10b5-1 | −24,423 | $15.49 | $378,312 | 590,429 | D |
| 2026-03-03 | Sale : show line 4 in the form 10b5-1 | −6,518 | $16.33 | $106,439 | 583,911 | D |
| 2026-03-04 | Exercise or conversion : show line 5 in the form 10b5-1 | +14,722 | $6.55 | $96,429 | 598,633 | D |
| 2026-03-04 | Exercise or conversion : show line 6 in the form 10b5-1 | +11,881 | $12.14 | $144,235 | 610,514 | D |
| 2026-03-04 | Sale : show line 7 in the form 10b5-1 | −30,941 | $16.60 | $513,621 | 579,573 | D |
| 2026-03-05 | Exercise or conversion : show line 8 in the form 10b5-1 | +14,722 | $6.55 | $96,429 | 594,295 | D |
| 2026-03-05 | Exercise or conversion : show line 9 in the form 10b5-1 | +11,881 | $12.14 | $144,235 | 606,176 | D |
| 2026-03-05 | Sale : show line 10 in the form 10b5-1 | −30,941 | $16.00 | $495,056 | 575,235 | D |
| Open-market sales · 92,823 sh · avg $16.09 · $1,493,428 | ||||||
Table II: Derivative
6 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-03 | Exercise or conversion : show line 11 in the form 10b5-1 Stock Option (right to buy) | −14,722 | 180,603 | D |
| 2026-03-03 | Exercise or conversion : show line 12 in the form 10b5-1 Stock Option (right to buy) | −11,881 | 451,463 | D |
| 2026-03-04 | Exercise or conversion : show line 13 in the form 10b5-1 Stock Option (right to buy) | −14,722 | 165,881 | D |
| 2026-03-04 | Exercise or conversion : show line 14 in the form 10b5-1 Stock Option (right to buy) | −11,881 | 439,582 | D |
| 2026-03-05 | Exercise or conversion : show line 15 in the form 10b5-1 Stock Option (right to buy) | −14,722 | 151,159 | D |
| 2026-03-05 | Exercise or conversion : show line 16 in the form 10b5-1 Stock Option (right to buy) | −11,881 | 427,701 | D |
Loading xslF345X05/primary_doc.xml…